Express Scripts — Merger or Acquisition (July 2011)
13 slides from Express Scripts's merger presentation, Jul 21, 2011
Slide 1: Express Scripts Management Briefing
Express Scripts Management Briefing July 21, 2011 George Paz, Chairman & CEO (c) 2011 Express Scripts, Inc. All Rights Reserved 1
Slide 2: Another Express Scripts Milestone
Another Express Scripts Milestone Thank You! Your hard work made this historic day possible. (c) 2011 Express Scripts, Inc. All Rights Reserved 2
Slide 3: An Historic Deal
An Historic Deal This is the combination the country needs now Cost and quality of healthcare are a great concern National mandate to lower cost of healthcare and improve care Accelerates our ability to drive out waste in healthcare Lower costs - improve the quality of care Builds upon our legacy of
Slide 4: Terms of the Deal
Terms of the Deal Jeff Hall Chief Financial Officer (c) 2011 Express Scripts, Inc. All Rights Reserved 4
Slide 5: Transaction Overview
Transaction Overview Price $28.80 cash and 0.81 of a share of Express Scripts stock (fixed exchange ratio); total consideration $29 billion Total value $71.36 per Medco share based on Express Scripts' closing stock price on July 20, 2011 Premium 28% to Medco shareholders based on Medco's closing sto
Slide 6: Transaction Overview: Ownership
Transaction Overview Ownership Express Scripts shareholders to own approximately 59% and Medco shareholders to own approximately 41% of the combined company Anticipated closing First half of 2012, subject to regulatory approvals (c) 2011 Express Scripts, Inc. All Rights Reserved 6
Slide 7: Significant Financial Benefits
Significant Financial Benefits Maintains Express Scripts' strong financial profile 2013 cash flow $4 billion+ of annual pro forma free cash flow generation Capex: disciplined capex deployment Credit Rating: commitment to maintaining investment grade credit rating Earnings Growth: maintain industry-l
Slide 8: Until the Transaction Closes (2012)
Until the Transaction Closes (2012) Both companies operate independently Do not share competitive or financial info Except as part of due diligence Each company responsible for communications with its clients, patients, suppliers, etc. (c) 2011 Express Scripts, Inc. All Rights Reserved 8
Slide 9: Client Perspective
Client Perspective Ed Ignaczak Executive Vice President Sales & Marketing (c) 2011 Express Scripts, Inc. All Rights Reserved 9
Slide 10: Forward-Looking Statements
Forward-Looking Statements Cautionary Note Regarding Forward-Looking Statements This material may include forward-looking statements, both with respect to us and our industry, that reflect our current views with respect to future events and financial performance. Statements that include the words "e
Slide 11: Forward-Looking Statements (cont.)
Forward-Looking Statements (cont.) TRANSACTION-RELATED FACTORS Uncertainty as to whether Express Scripts, Inc. (Express Scripts) will be able to consummate the transaction with Medco Health Solutions, Inc. (Medco) on the terms set forth in the merger agreement; The ability to obtain governmental app
Slide 12: Additional Information and Where to Find It
Additional Information and Where to Find It This communication is not a solicitation of a proxy from any stockholder of Express Scripts, Medco or Express Scripts Holding Company. In connection with the Agreement and Plan of Merger among Medco, Express Scripts, Express Scripts Holding Company, Plato
Slide 13: Questions?
Questions? (c) 2011 Express Scripts, Inc. All Rights Reserved 13